The clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological tests.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of the treatment of JC PCR requires individualized development, usually including multidimensional management of drug therapy, rehabilitation, regular follow-up, and so on. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for effectiveness and adverse reactions, adjusted in a timely manner according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-companied cerebrospinal fluid JC PCR. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.